Medtech company Synaptive Medical said this week it released the Modus V, a 2nd-gen digital microscope and robotic arm designed to work with its BrightMatter robot-assisted surgical platform.

The Toronto-based company said the Modus V includes advanced instrument tracking and automatic focus to enable greater surgical efficiency and hands-free control.

“This product release marks a major milestone in our evolution as a company. Modus V is an integral part of our overall BrightMatter surgical solution. Conceptualized for the digital era as a fully integrated set of devices, our solution collects and delivers data—be it imaging, tractography or other patient information—when and where it’s most needed to drive surgical decision making. It’s part of our ongoing commitment to give surgeons the most advanced tools with which to treat their patients,” CEO Peter Wehrly said in a prepared statement.

“Collaboration is hardwired into Synaptive’s culture. Modus V’s improvements are grounded in the collaboration and extensive feedback from neurosurgeons in our customer community on both Modus V prototypes and BrightMatter Drive. We’re grateful for their support, and look forward to deeper commentary from the surgical community as Modus V enters the market,” prez & chief strategy officer Cameron Piron said in a press release.

In April, Synaptive Medical said it won CE Mark clearance in the European Union and regulatory approval in Australia for its BrightMatter Plan neurosurgical planning system. The system automatically generates 3D pictures of the brain, allowing surgeons to craft accurate preoperative plans, the company said.